Clinical trial NCT06162936: Neutrophil Oxidative Burst in Early and Late Onset Pediatric Inflammatory Bowel Disease
Official title: Neutrophil Oxidative Burst in Early and Late Onset Pediatric Inflammatory Bowel Disease
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Chronic Granulomatous Disease
Keywords: inflammatory bowel disease
chronic granulomatous disease
inborn errors of immunity
Lead sponsor: National Institute for Mother and Child Health Alessandrescu Rusescu
Sponsor class: OTHER
Collaborators: name: Marie Curie Emergency Children's Hospital, Bucharest
name: Victor Gomoiu Children's Hospital, Bucharest
First posted: 2023-12-08
Enrollment: 150
Sex: ALL
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The study population will include pediatric patients diagnosed with IBD (right from the diagnosis or anytime during the disease course) from three different gastroenterology units in Bucharest, Romania.

Screening tests for an imunological disease (neutrophil oxidative burst, lymphocyte subsets) will be performed in included patients and healthy controls by the home institution.

Brief summary: ABSTRACT Introduction Residual or absent oxidase function in peripheral neutrophils may point to an inborn defect of neutrophil function - chronic granulomatous disease (CGD) - whereas low to normal oxidative burst capacity has been linked to variants in various members of the NADPH-complex.

Aims To assess the clinical value of routinely measuring oxidative burst activity of granulocytes in pediatric patients diagnosed with very early onset IBD (VEO-IBD) and late onset IBD.

Objectives To investigate possible correlations between neutrophil function and IBD disease activity and to inquire the presence of genetic variants in those with low to absent oxidative burst. To identify the rate of monogenic VEO-IBD in our cohort.

Materials and Methods The proposal constitutes a collaborative effort among Romanian pediatric tertiary care centers to examine the value of assessing neutrophil function in all pediatric IBD patients. Children aged \<18 years diagnosed with Crohn's disease, ulcerative colitis or IBD-undetermined and age-matched healthy controls are recruited. A DHR flow cytometry assay is performed in included subjects and controls. Reduced or absent burst activity will lead to genetic testing in search of overt immunodeficiency or susceptibility variants. All VEO-IBD patients will have an immunological work-up in search of a primary immunodeficiency.

Expected Results We anticipate to include a number of 150 pediatric patients with IBD over 12 months from the three pediatric gastroenterology units in Bucharest, Romania. We expect to identify an overall diminished neutrophil function in IBD patients versus controls and possible variants in the NADPH-complex genes.


Eligibility criteria: Inclusion Criteria:

Subjects:

1. age under 18 years;
2. confirmed diagnosis of IBD fulfilling standard diagnosis criteria (clinical, radiological, endoscopical, histological features)
3. parental/guardian consent for study enrollment

Controls:

Healthy age-gender matched controls

Exclusion Criteria:

1. IBD associated to an already defined monogenic defect
2. Diagnosis of IBD uncertain
3. HIV/TB positive

Primary outcomes:
measure: Oxidative burst activity in IBD patients
timeFrame: 12 months
measure: Genetic testing in patients with suspicion of IEI
timeFrame: 12 months
Secondary outcomes:
measure: Role of burst activity in disease phenotype
timeFrame: 12 months
Other outcomes:
Locations:
city: Bucharest
country: Romania
facility: National Institute for Mother and Child Health Alessandrescu Rusescu
state: County
Study officials:
References: